As the United States and countries across the globe recover from the scourge and ravages of COVID-19, scientists, healthcare professionals and other stakeholders proffer mitigative models that aspire to contain and constrain the pandemic.

In the mad race to the coveted price of an antibody and/or vaccine, drugs such as remdesivir, hydrochloroquine etc., have achieved instant but singular notoriety. As the pharmaceutical industry undertakes clinical trials and makes pharmacokinetic and pharmacodynamic determinations on certain drugs of particular interest, it once again presents an opportunity for discussions on the place of complementary and alternative medicinal products in the treatment of acute and chronic disorders.

To accommodate proposals that may fit this, and other narratives, the editor requested for and secured from the publisher, an extension of the schedule of deadlines for the SEEED-IGI Global book entitled “Exploring the Efficacy and Beneficence of Complementary and Alternative Medicinal Products in Disease Therapy.” Consequently, the editorial advisory board (EAB) renews its call for book chapter contributions that are apropos: https://www.igi-global.com/publish/call-for-papers/call-details/4155. 

Please direct all inquiries to the editor: Etetor Roland Eshiet; Email: etetoreshiet@yahoo.com, etetor.eshiet@see-ed.com; Tel: +1 713.714.7477.